Biotech China 2014
19th Annual Symposium on Current Issues And New Techniques In Interventional Radiology And Endovascular Therapy
Hilton New York
1335 Avenue Of The Americas New York, NY 10019 (between 53rd and 54th Streets)
New York, New York ,USA
http://www.veithsymposium.com/aim.php?pg=home
Vascular disease is a leading cause of disability and death in patients over age 50. Nonvascular intervention, especially in oncology patients, continues to increase in most busy practices. As such, there is a critical need for physicians who manage these patients to receive CME in this area. To address this need, the AIMsymposium will review the latest pharmacologic, radiologic, surgical and endovascular techniques and technologies as well as discuss when these treatments are justified and indicated and when they are not. Updates on clinical trials and opportunities for dialogue with experts in the field will provide insight, along with the latest data on the results of the various treatment modalities.

The Advanced Interventional Management Symposium (AIMsymposiumTM) will be held Wednesday - Friday, November 16 - 18, 2011. The scientific sessions, mini-courses, panel discussions and case presentations, presented by a nationally renowned faculty, will provide a concise overview of the most current issues and hands-on experience in new techniques in percutaneous, endovascular and surgical treatment methods. Highlights of the meeting will include hands-on workshops, didactic workshops, cases and joint sessions with the 38th VEITHsymposium.TM There will be special emphasis on interventional oncology, PVD, aneurysms, embolization devices, CCSVI, TIPS, fibroid management, vascular imaging, neurointervention, fibroid management, hemodialysis access and venous interventions.

   1. To acquire new knowledge in the diagnosis and treatment of peripheral vascular disease
   2. To be able to diagnose and treat abdominal aortic aneurysms in a minimally invasive manner
   3. To be able to diagnose and treat various types of tumors with embolic agents and radiofrequency ablation using imaging
   4. To review the normal anatomy and the pathology of veins in the lower extremities
   5. To apply new knowledge of carotid stenting techniques to the participants practice
   6. To describe the various methods of maintaining vascular access in the dialysis patient

Medical Simulators In Interventional Radiology - Friday, November 18, 2011 (Murray Hill Suite A, 2nd Floor)

The Simbionix PROcedure Rehearsal Studio software allows clinicians to create a patient specific 3D anatomical model based on a patient's CT for the purpose of simulating, analyzing and evaluating for preoperative surgical treatment options. Once the 3D segmentation model has been exported to the Simbionix ANGIO Mentor Simulator Practice Environment, physicians can use it to create an ever expanding library of modules for training and postoperative debriefing. Gain hands-on experience with true-to-life tactile feedback of a real procedure. This training/workshop is open to those seeking to improve their imaging skills. This training workshop will be available in conjunction with the Friday workshops (please see Session 15 of the program).
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 27.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
http://www.veithsymposium.com/aim.php?pg=home

Schedule of Presentations:

Wednesday, November 16, 2011
07:50:00 SESSION 3 | MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 1
07:50:00 Session 3 | Welcome And Introduction Allan L. Brook
07:50:00 Session 1 | Introduction
07:50:00 SESSION 1: HEMODIALYSIS ACCESS (PART 1)
07:55:00 Session 1 | PART 1A: INTERVENTIONAL PROCEDURES FOR HEMODIALYSIS ACCESS (8-MINUTE TALKS) Larry A. Scher
07:55:00 SESSION 5 | ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 1 (7-MINUTE TALKS) Lowell S. Kabnick, Jose I. Almeida
07:55:00 Session 3 | PART 1A: THE BASICS OF STROKE Allan L. Brook
08:00:00 Session 5 | Welcome – Endovascular Venous Surgery At A Glance Jose I. Almeida
08:00:00 Session 1 | Central Venous Access: Avoiding Complications In The Dialysis Population Jacob Cynamon
08:00:00 Session 3 | Collateral Circulation In Acute Ischemic Stroke: Clinical, Imaging, And Therapeutic Correlates David S. Liebeskind
08:10:00 Session 5 | Anatomy And Nomenclature Of The Venous System
08:10:00 Session 1 | Balloon Access Maturation Using Duplex Ultrasound Enrico Ascher
08:15:00 Session 1 | Angioplasty vs. Stent Graft Bart L. Dolmatch
08:15:00 Session 5 | View Abstract
08:15:00 Session 3 | Brain Attacks Is Different From Heart Attack! Why This Matters And Its Implications Robert W. Tarr
08:20:00 Session 5 | Detecting Superficial Venous Disease With Duplex Ultrasound
08:25:00 Session 1 | View Abstract
08:25:00 Session 5 | View Abstract
08:30:00 Session 3 | View Abstract
08:30:00 Session 1 | AV Fistula Thrombectomy
08:30:00 Session 5 | Detecting Pathological Non Saphenous Veins Of The Lower Extremities By Duplex Ultrasound Diana L. Neuhardt
08:35:00 Session 5 | Detecting Iliac, IVC, Ovarian Vessels By Duplex Ultrasound: Tips, Tricks And Significance
08:35:00 Session 1 | Thrombectomy Devices For AV Graft Thrombosis Claudio J. Schonholz
08:35:00 Session 3 | Stroke Mimics And Why We Can’t Miss Early Opportunities To Triage And Treat Daniel Labovitz
08:40:00 Session 5 | Endothermal Ablation Of The GSV Antonios P. Gasparis
08:45:00 Session 1 | Use Of The Amplatzer II Device Steven Powell
08:45:00 Session 5 | View Abstract
08:45:00 Session 3 | Door To Revascularization Time: Optimization And Where Will We Be In 5 Years And Why Don Frei
08:50:00 Session 5 | Endothermal Ablation Of The SSV
08:55:00 Session 1 | Salvaging The Unsalvageable Fistula
08:55:00 Session 5 | Can Saphenous And Sural Nerve Paresthesia Be Prevented?
08:55:00 Session 3 | Discussion
09:05:00 Session 1 | Management Of Cephalic Arch Stenosis Gregg A Miller
09:05:00 Session 5 | Pathophysiology Of Varicose Veins - Descending And Ascending Theory: Implications Of Treatment Alun H. Davies
09:10:00 Session 5 | View Abstract
09:10:00 Session 3 | PART 1B: STATE-OF-THE-ART IMAGING
09:15:00 Session 5 | Iliac Vein Obstruction With Concomitant Femoral Vein Reflux: Stent The Iliac Vein, Observe The Femoral Vein
09:15:00 Session 3 | Does Clot Composition And Size Really Matter? Todd S. Miller
09:15:00 Session 1 | Central Venous Stenosis: Percutaneous Management Bart L. Dolmatch
09:20:00 Session 1 | View Abstract
09:20:00 Session 5 | For C6 Disease: Concomitant Saphenous And Perforator Ablation? Before Or After The Ulcer Heals?
09:25:00 Session 3 | The Acute Stroke-Imaging Protocol Made Easy And My Own Pearls Meng Law
09:25:00 Session 1 | Central Venous Stenosis: Surgical Management Karl A. Illig
09:30:00 Session 1 | Panel Discussion
09:30:00 Session 5 | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
09:35:00 Session 3 | Summarization Of The Latest Trials And Learning Points
09:40:00 Session 5 | Natural History And Progression Of DVT: How To Prevent And Treat Post Thrombotic Syndrome Anthony J. Comerota
09:45:00 Session 5 | View Abstract
09:50:00 Session 5 | Pharmacomechanical Thrombolysis For DVT: Midterm Outcomes With ISOL-8 Study Hiranya A. Rajasinghe
09:50:00 Session 3 | The Malignant Profile And Its Implications David S. Liebeskind
09:55:00 Session 3 | Discussion
09:55:00 Session 5 | View Abstract
09:55:00 Session 1 | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
10:00:00 Session 5 | DVT Intervention: What Tools Are Available? Which Ones Work Best? Alan M. Dietzek
10:05:00 Session 5 | What Is The Skinny On Caval Interruption? Overuse? Robert B. McLafferty
10:10:00 Session 1 | PART 1B: CLINICAL PRACTICE ISSUES (8-MINUTE TALKS) Joseph N. Shams
10:15:00 Session 5 | Debate (5 Minutes): Thrombophilia: Hypercoagulable Testing Is Needed In Most Cases Timothy K. Liem
10:15:00 Session 3 | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
10:15:00 Session 1 | Vascular Access Planning For The Pre-Dialysis Patient
10:20:00 Session 5 | Debate (5 Minutes): Thrombophilia: Hypercoagulable Testing Is Not Needed Mark H. Meissner
10:25:00 Session 5 | Thrombus Extension At The SFJ (EHHIT 2) After Endothermal Ablation: Should We Worry? Lowell S. Kabnick
10:25:00 Session 3 | PART 1C: TRIAGE ISSUES AND DEBATES Dorothea Altschul
10:25:00 Session 1 | Fistula First Clarifies Its Message: What Are Realistic Goals?
10:30:00 Session 3 | State-Of-The-Art Triage Via The Clinical Exam And Why It Still Is Best Steven H. Rudolph
10:30:00 Session 5 | How To Treat Ascending GSV Superficial Thrombophlebitis Thomas W. Wakefield
10:30:00 Session 1 | View Abstract
10:35:00 Session 3 | State-Of-The-Art Triage Via CT: Quick And Easy Raul G. Nogueira
10:35:00 Session 1 | Fistula Cannulation: Science And Practice Sandra M. Donnelly
10:40:00 Session 5 | Graduated Compression Hose Post Ablation: Do They Make A Difference?
10:45:00 Session 3 | State-Of-The-Art Triage Via MR: Sophisticated And Quick!
10:45:00 Session 1 | Vascular Access Surveillance Thomas M. Vesely
10:50:00 Session 3 | Legal Issues And The Consent Process When Treating Stroke Patients
10:50:00 Session 1 | View Abstract
10:50:00 Session 5 | A Technically Perfect Phlebectomy Is Better Than Sclerotherapy For Bulging Varicose Veins
10:55:00 Session 1 | Update Of Hemodialysis Access Coding
10:55:00 Session 5 | Issues On Ulcer Healing Thomas F. O'Donnell
11:00:00 Session 5 | View Abstract
11:00:00 Session 3 | View Abstract
11:00:00 Session 1 | Prevention Of Vascular Access Infection
11:05:00 Session 3 | Discussion
11:05:00 Session 5 | Unna’s Boot Any Progress? David L. Gillespie
11:10:00 Session 5 | Terminal Interruption Of The Reflux Source: For Venous Ulcers Ronald G. Bush
11:10:00 Session 3 | PART 1D: ACUTE STROKE MANAGEMENT Ajay Wakhloo
11:10:00 Session 1 | Is Anticoagulation Ever Appropriate For Recurrent Access Thrombosis? Jeffrey H. Lawson
11:15:00 Session 3 | IV TPA Recent Updated Guidelines: Does 3, 4, Or 6 Hours Really Have A Basis In The Literature Or In Pathophysiology? Osama O. Zaidat
11:20:00 Session 3 | IA Thrombolytics And Antiplatelet Nuances: When To Best Utilize And Why
11:20:00 Session 1 | Steal Syndrome Associated With BAM: Incidence And Management Gregg A Miller
11:20:00 Session 5 | Other Pelvic Venous Syndromes And Treatment
11:30:00 Session 3 | MERCI Retrieval: Summary Of The Clotted Data And Outcomes Raul G. Nogueira
11:30:00 Session 5 | Is It Important To Have A Standalone Venous Fellowship?
11:30:00 Session 1 | Hemodialysis Catheters Through Occluded Veins Steven Powell
11:35:00 Session 5 | View Abstract
11:35:00 Session 1 | View Abstract
11:40:00 Session 1 | Panel Discussion
11:40:00 Session 5 | Ask The Panel Thomas F. O'Donnell, Mark H. Meissner, Robert B. McLafferty, Lowell S. Kabnick, Alun H. Davies, Anthony J. Comerota, Jose I. Almeida
11:40:00 Session 3 | Penumbra Thrombectomy: Sucking The Relevant Safety And Efficacy Out Of The Literature: Do The Outcomes Justify?
11:50:00 Session 3 | Angioplasty And Stenting In The Acute Stroke Setting: Facts And Fiction: My Opinion! David Fiorella
12:00:00 Session 5 | Lunch Break - Americas Hall I, 3rd Floor Visit Exhibis and Pavilions (2nd and 3rd Floors)
12:00:00 Session 1 | Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
12:00:00 Session 3 | Is Stenting Or Temporary Stenting The Holy Grail In Revascularization? Ajay Wakhloo
12:05:00 Session 5 | END OF SESSION 5
12:10:00 Session 3 | Discussion
12:10:00 Session 3 | END OF SESSION 3
12:15:00 SESSION 4 | MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 2
12:20:00 Session 4 | PART 2A: WHAT WENT WRONG WITH THE TRIALS: THE PATIENT SELECTION, THE OPERATORS, OR LACK OF UNDERSTANDING THE INTRICACIES OF THE LESION PATHOPHYSIOLOGY AND TIMING OF THE THERAPY? (LUNCH WILL BE AVAILABLE) Allan L. Brook
12:25:00 SESSION 6 | ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 2 (7-MINUTE TALKS) Lowell S. Kabnick, Jose I. Almeida
12:25:00 Session 6 | View Abstract
12:30:00 Session 4 | CREST: Latest Summary From The PI And Future Implications Thomas G. Brott
12:30:00 Session 6 | Review Of Randomized Controlled Trials Comparing Endovenous Thermal Ablation, Stripping, And Foam Sclerotherapy For Varicose Veins
12:30:00 Session 1 | END OF SESSION 1
12:35:00 SESSION 2 | PART 2A: POLITICAL ISSUES IN HEMODIALYSIS ACCESS (8-MINUTE TALKS)
12:35:00 SESSION 2: HEMODIALYSIS ACCESS - PART 2 (8-MINUTE TALKS)
12:35:00 Session 6 | View Abstract
12:40:00 Session 4 | DEBATE: Carotid Stenting: Cases That Absolutely Warrant Stenting Mark H. Wholey
12:40:00 Session 6 | Should We Divide C2 Classification? How? Eberhard Rabe
12:45:00 Session 6 | How To Use CEAP And VCSS In Clinical Practice Sherif Sultan
12:45:00 SESSION 2 | Impact Of Health Care Reform On Hemodialysis Access Curtis W. Bakal
12:50:00 Session 4 | DEBATE: Carotid Endarterectomy: Why Surgery Is The Standard Of Care
12:55:00 Session 4 | Discussion
12:55:00 Session 6 | Quality Of Life Tools Should Not Be Used As A Method To Ration Intervention Alun H. Davies
12:55:00 SESSION 2 | Hemodialysis Access: The Canadian Perspective Sandra M. Donnelly
13:00:00 Session 6 | View Abstract
13:05:00 Session 6 | Who Benefits Most From Varicose Veins Endovenous Treatment? Mark H. Meissner
13:05:00 SESSION 2 | Physician-Industry Relations In The Era Of AdvaMed
13:10:00 SESSION 2 | View Abstract
13:10:00 Session 6 | Review Of SVS And AVF Consensus On The Treatment Of Superficial Venous Disease Peter Gloviczki
13:15:00 Session 4 | SAMMPRIS: Summary From The PI And Future Implications Colin P. Derdeyn
13:15:00 SESSION 2 | Credentialing Vascular Access Procedures
13:20:00 Session 4 | View Abstract
13:20:00 Session 6 | Endovenous Saphenous Ablation Corrects The Hemodynamic Abnormality In C3-C6 Disease
13:25:00 Session 6 | Updates On Venous Recurrence And Its Management
13:25:00 Session 4 | Intracranial Stenting: Ideal Cases Clinically, Technically, And Why Colin P. Derdeyn
13:25:00 SESSION 2 | Panel Discussion
13:30:00 SESSION 2 | PART 2B: NEW TECHNOLOGY AND CONCEPTS IN HEMODIALYSIS ACCESS (7-MINUTE TALKS) Thomas M. Vesely, Larry A. Scher
13:30:00 Session 4 | View Abstract
13:35:00 Session 4 | Discussion
13:35:00 SESSION 2 | Revision Of Hemodialysis Access Using The Gore Hybrid Graft John Ross
13:35:00 Session 6 | Long Wavelength Lasers Allow Usage Of Less Power And Energy During EVLT Lowell S. Kabnick
13:40:00 Session 4 | PART 2B: THE OTHER SIDE OF STROKE: SUBARACHNOID HEMORRHAGE MANAGEMENT Dorothea Altschul
13:45:00 Session 6 | Endovenous Thermal Ablation: Technical Pearls For Complex Anatomy Jose I. Almeida
13:45:00 SESSION 2 | Heparin Bonded vs. Standard Grafts For Hemodialysis Access
13:45:00 Session 4 | Subarachnoid Hemorrhage: Natural History And Summary Of Latest Aneurysm Trials Aman Patel
13:50:00 Session 6 | What’s New From The Bench: Venous Research Joseph Raffetto
13:50:00 SESSION 2 | View Abstract
13:55:00 Session 4 | Resuscitation Of Poor Grade Subarachnoid Hemorrhage Kiwon Lee
13:55:00 Session 6 | View Abstract
13:55:00 SESSION 2 | Drug Coated Balloon Angioplasty In Hemodialysis Access Konstantinos Katsanos
14:00:00 Session 6 | Which Imaging Techniques Can Help Doctors Better Understand The Pathological Relationships Between The Superficial And Deep Systems? Barry Eisenstein
14:00:00 SESSION 2 | View Abstract
14:05:00 SESSION 2 | View Abstract
14:05:00 Session 4 | Latest Devices For Aneurysm Therapy And What Percentage Of Patients Will They Have An Impact On Peter K. Nelson
14:05:00 SESSION 2 | Endoscopic Surgery For AV Fistula Creation
14:05:00 Session 6 | Chronic CerebroSpinal Venous Insufficiency: Is This a Real Syndrome? Mark H. Meissner
14:10:00 SESSION 2 | Recombinant Human Elastase For Improved Vascular Access David Leeser
14:15:00 New Session 6 | 3-Year Update With Radiofrequency Thermal Ablation Alan M. Dietzek
14:15:00 Session 4 | Surgical Clipping Of Aneurysms Is Still A Necessary Evil: Case Selection From An Experienced Cerebrovascular Neurosurgeon Eugene S. Flamm
14:15:00 SESSION 2 | HeRO Device Jeffrey H. Lawson
14:20:00 Session 6 | Histological Findings After Endovenous Radiofrequency Therapy In Varicose Veins Karin Brachmann
14:25:00 SESSION 2 | New Advances In Combating Dialysis Graft Infections A. Frederick Schild
14:25:00 Session 4 | Endovascular Cases That Make Me Nervous: Location, Geometry, And Strategies David Fiorella
14:30:00 Session 6 | Which One: Sclerotherapy, Phlebectomy, Or Trivex For Bulging Varicose Veins?
14:35:00 Session 4 | Unruptured Aneurysms: Why Do We Treat And How I Consent The Patient
14:35:00 Session 6 | View Abstract
14:35:00 SESSION 2 | Improved AV Fistula Maturation With Sirolimus
14:40:00 Session 6 | Debate (5 Minutes): We Should Treat Calf Vein DVT With Standard Anticoagulation
14:40:00 SESSION 2 | Panel Discussion
14:45:00 Session 4 | Large Aneurysm Strategies: Combined Approaches Aaron S. Dumont
14:45:00 Session 6 | Debate (5 Minutes): We Should Not Treat Calf Vein DVT With Standard Anticoagulation
14:50:00 Session 6 | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
14:55:00 SESSION 2 | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
14:55:00 Session 4 | Sinus Thrombosis: Management Strategies And When To Treat Interventionally
15:05:00 Session 4 | Carotid And Vertebral Blowout: Best Management
15:05:00 Session 6 | The Importance Of The American Venous Forum Registry
15:10:00 Session 6 | No Single Modality Of Venous Treatment Fits All Mark A. mark.adelman@med.nyu.edu Adelman
15:10:00 SESSION 2 | PART 2C: UPDATE ON SURGICAL PROCEDURES IN HEMODIALYSIS ACCESS (8-MINUTE TALKS) Mitchell L. Henry
15:15:00 Session 4 | Discussion
15:15:00 SESSION 2 | Treatment Of AV Fistula Aneurysms Without Temporary Catheters Surendra Shenoy
15:20:00 Session 6 | Lymphatic Complications After VV Surgery: Risk Factors And How To Avoid It
15:25:00 SESSION 2 | Surgical Repair Of Aneurysmal Fistulas
15:30:00 Session 4 | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
15:30:00 Session 6 | Should Adjuvant Procedures Be Performed At The Same Time As Endothermal Ablation? Evidenced Based
15:35:00 SESSION 2 | Vascular Access In The Elderly: Algorithms For Successful Management
15:35:00 Session 6 | Modern Day Stripping Is As Good As Endothermal Ablation
15:35:00 Session 4 | PART 2C: APPROACHES AND STRATEGIES TO DIFFICULT CASES Allan L. Brook
15:45:00 SESSION 2 | Hemodialysis Access In The Patient With Lupus Mitchell L. Henry
15:45:00 Session 6 | Ultrasound Shows Superficial Axial Reflux With Either DVT Or Deep Venous Insufficiency: What Do You Do Next? Apostolos K. Tassiopoulos
15:45:00 Session 4 | Discussion, Questions & Answers: Panel And Audience Participation
15:50:00 Session 6 | What Is The Skinny On Perforator Interruption? Overuse?
15:50:00 SESSION 2 | View Abstract
15:55:00 SESSION 2 | Lower Extremity Hemodialysis Access
16:00:00 SESSION 2 | Use Of The Brachial Vein For Autogenous Hemodialysis Access
16:00:00 Session 6 | Data On 300 Patients Treated With GSV Pharmacomechanical Ablation Jean-Paul de Vries
16:05:00 SESSION 2 | View Abstract
16:10:00 New Session 6 | Saphenous Vein Ablation With Glue Jose I. Almeida
16:10:00 SESSION 2 | When Is Banding Appropriate To Treat Steal Syndrome?
16:15:00 SESSION 2 | View Abstract
16:15:00 Session 6 | Comparison Of Laser, Ohmic Thermolysis, And Sclerotherapy For Spider Telangiectasia Ronald G. Bush
16:20:00 SESSION 2 | Proximal Radial Artery Fistula
16:25:00 Session 6 | Air vs. Physiological Gas For Ultrasound Guided Foam Sclerotherapy
16:30:00 SESSION 2 | When Should Functioning AV Fistulas Be Ligated After Renal Transplantation Stuart M. Greenstein
16:35:00 Session 6 | Ask The Panel Mark H. Meissner, Lowell S. Kabnick, Peter Gloviczki, Jose I. Almeida
16:40:00 SESSION 2 | Panel Discussion
16:45:00 SESSION 2 | PART 2D: HOW I DO IT: VIDEO SESSION (8-MINUTE TALKS) Larry A. Scher
16:55:00 SESSION 2 | Slot Technique To Prevent Juxtaanastomotic Stenosis Surendra Shenoy
17:00:00 Session 4 | Adjourn
17:00:00 Session 6 | Adjourn. Visit Exhibits and Pavilions (2nd and 3rd Floors)
17:05:00 SESSION 2 | Technique For Forearm AV Graft Placement Mitchell L. Henry
17:05:00 Session 6 | END OF SESSION 6
17:05:00 Session 4 | END OF SESSION 4
17:15:00 SESSION 2 | Lipectomy For AV Fistula Superficialization
17:25:00 SESSION 2 | Minimal Incision Basilic Vein Transposition
17:30:00 SESSION 2 | Hemodialysis Access Program Adjourns
17:35:00 SESSION 2 | END OF SESSION 2
Thursday, November 17, 2011
06:20:00 SESSION 7 | LOWER EXTREMITY HOT TOPICS 1 (5-MINUTE TALKS) Enrico Ascher, Kim J. Hodgson
06:30:00 PROGRAM B (SESSIONS 14-16) LOCATION: TRIANON BALLROOM, 3RD FLOOR
06:35:00 Opening Remarks
06:40:00 Optimizing POBA With Focal Force Balloons: What Are They And Do They Work With Heavily Calcified Arteries Craig M. Walker
06:45:00 Tips And Tricks For Antegrade Puncture Of The CFA: How To Get The Wire Easily Into The SFA
06:50:00 View Abstract
06:55:00 When And How To Use Embolic Protection Devices In The Lower Extremity
06:55:00 PTA (POBA) vs. Stenting For SFA/Popliteal Disease: Are Late Outcomes Equivalent
06:55:00 View Abstract
07:00:00 Endovascular vs. Open Surgical Treatments: A Common Sense Approach To The TASC System Jos C. van den Berg
07:05:00 View Abstract
07:10:00 Role Of Bare Metal Stents For Below Knee Lesions Causing CLI: When Do They Help And When Not: Results Of The Belgian BTK Trial: What Is The Need For Reintervention At 1 Year Frank E.G. Vermassen
07:15:00 Advantages And Limitations Of Drug Eluting Balloons (DEBs): Do They Improve On The Results Of PTA With Uncoated Balloons For The Treatment Of Primary Lesions And After Atherectomy Gunnar Tepe
07:20:00 What Is The Effectiveness Of The Angioslide Embolic Debris Capture Device And When Should It Be Used Thomas Zeller
07:25:00 Supera Veritas Stent: Why Is It A Better Solution For Extensive Femoropopliteal Disease
07:30:00 Panel Discussion
07:35:00 END OF SESSION 7
08:35:00 SESSION 9 | LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS) Max Amor, George H. Meier
08:40:00 PROGRAM B (SESSIONS 14-16) LOCATION: TRIANON BALLROOM, 3RD FLOOR
08:45:00 DEBATE: In Lower Extremity PTAs Intraluminal Is Better Than Subintimal
08:50:00 DEBATE: Nonsense, In Lower Extremity PTAs, Subintimal Is Better George H. Meier
08:55:00 Should PTAs Of The SFA Always Be Stented: Based On Prospective Follow-up Of 850 Patients Robert Y. Rhee
09:00:00 View Abstract
09:05:00 Another View On Embolization During Lower Extremity Interventions: When Is Embolic Protection Needed And How Should It Be Done Nicholas J. Morrissey
09:10:00 Tips And Tricks For Reentry Into The Lumen From The Subintimal Space
09:15:00 View Abstract
09:20:00 Does Debulking Before Using DEBs Help With Primary Atherosclerotic Lesions; With In-Stent Restenosis: How Should It Be Done Dierk Scheinert
09:20:00 Another Single Center Experience With The Value Of DEBs For Femoropopliteal Lesions
09:30:00 Some Negative Aspects Of Tibial Angioplasty Based On U.S. Medicare Data In Patients With CLI: Complications, Rehospitalizations And Amputations Are Frequent After The Procedure Alan M. Graham
09:35:00 Value Of Atherectomy Devices And Lasers For Lower Extremity Occlusive Lesions: Which Ones Make A Difference And When Should They Be Used Thomas Zeller
09:40:00 Long-Term Results Of Ultrasound Enhanced Thrombolysis For Acute Arterial Occlusions: Results Of The Dutch Multicenter Study Jean-Paul de Vries
09:45:00 Panel Discussion
09:50:00 Break - Visit Exhibits and Pavilions (2nd and 3rd Floors)
09:55:00 END OF SESSION 9
10:05:00 SESSION 10 | MISCELLANEOUS TOPICS OF INTEREST TO INTERVENTIONAL RADIOLOGISTS Robert Lookstein
10:10:00 Patient And Public Advocacy: How The Internet Impacts On What We Do
10:20:00 How To Use Vascular Imaging To Bolster Your Interventional Practice Barry Eisenstein
10:30:00 What Does Interventional Radiology Bring To The Table In The Treatment Of PVD?
10:40:00 Preclose Technique For Percutaneous EVAR And TEVAR: A Step By Step Tutorial With Technical Pearls And Clinical Outcomes Ripal T. Gandhi
10:45:00 View Abstract
10:50:00 Renal Artery Intervention: PTA/Stents vs. Denervation Marc Sapoval
11:00:00 CO2 Angiography James Caridi
11:05:00 View Abstract
11:10:00 Vascular Imaging In The Setting Of Trauma Eli Atar
11:15:00 View Abstract
11:20:00 A Non-Closure Closure Device Jacob Cynamon
11:30:00 Early TIPS For Ascites: Does It Really Make A Difference?
11:40:00 Biliary Stents: Covered Or Uncovered, That Is The Question
11:50:00 CCSVI: What Have We Learned In The Past Year? Salvatore J.A. Sclafani
12:00:00 END OF SESSION 10
12:00:00 Lunch Break - Americas Hall I, 3rd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors)
12:00:00 Opening Remarks
12:05:00 SESSION 11 | LUNCHEON PROGRAM: MANAGEMENT OF PROXIMAL VENOUS OBSTRUCTION. (PRE-REGISTRATION IS REQUIRED. PLEASE E-MAIL ADMIN@VEITHSYMPOSIUM.ORG TO PRE-REGISTER COMPLIMENTARY.)
12:05:00 Is There A Role For Thrombolysis And/Or Mechanical Thrombectomy In Acute Proximal Deep Venous Thrombosis Anthony J. Comerota
12:05:00 SPECIAL LUNCHEON SESSION - LOCATION: CONFERENCE ROOM A, CONCOURSE LEVEL
12:10:00 View Abstract
12:15:00 The Use Of Venous Stenting For Subacute And Chronic Proximal Venous Obstruction
12:25:00 Open Surgical Procedures Are Best For Obstruction Of The Iliofemoral Veins And Inferior Vena Cava Peter Gloviczki
12:35:00 Discussion And Closing Remarks
12:50:00 END OF SESSION 11
12:50:00 Adjourn - Transition to Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor; AIMsymposium continues in the Trianon Ballroom, 3rd Floor.
12:55:00 SESSION 12 | METASTATIC LIVER DISEASE Daniel Y. Sze, David C. Madoff
13:00:00 Imaging Strategies To Assess Extent Of Disease And Results Of Therapy
13:10:00 Systemic And Neoadjuvant Therapy For Colorectal Disease Andreas Kaubisch
13:20:00 Debate: TACE Is Best For Colorectal Metastases To The Liver Michael Soulen
13:30:00 Debate: y-90 Should Be The Gold Standard For Colorectal Metastatic Liver Disease Matthew S. Johnson
13:35:00 View Abstract
13:40:00 Evolution Of A New Treatment Modality For Metastatic Liver Cancer From Major Surgery To Percutaneous Intervention Steven K. Libutti
13:50:00 Chemoperfusion For Metastatic Liver Disease Bradford Wood
14:00:00 When Is Surgery Indicated For Metastatic Liver Lesions? Milan Kinkhabwala
14:10:00 Ablation Therapy Should Be Used In Combination With Other Therapies Riccardo Lencioni
14:20:00 Management Of Neuroendocrine Tumors
14:30:00 Chemoperfusion For Neuroendocrine Tumors: Early Results Bradford Wood
14:40:00 Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
14:45:00 END OF SESSION 12
14:50:00 SESSION 13 | HEPATOCELLULAR CARCINOMA Curtis W. Bakal
14:55:00 Assessment, Staging And Triage Of Patients With HCC Daniel Y. Sze
15:00:00 Debate: Conventional TACE: How To Do It And Why It Is Best Michael Soulen
15:10:00 Debate: TACE Using DEB Is Best: How I Do It And The Value Of Periprocedure Anti-Angiogenesis Therapy
15:30:00 Debate: y-90 Is The Best Treatment For HCC Riad Salem
15:40:00 Immediate CT Post DEB TACE Helps Predict Adequacy Of TACE Jacob Cynamon
15:50:00 Finding The Obscure Vessel Feeding The Tumor Jonathan Susman
16:00:00 Indications, Technique And Assessment Of PV Embolization David C. Madoff
16:10:00 Overview Of The Various Ablation Devices Riccardo Lencioni
16:20:00 Biopsy After Ablation: What To Look For And Why It Should Be Standard Of Care Constantinos Sofocleous
16:30:00 HIFU For HCC Franco Orsi
16:35:00 View Abstract
16:40:00 When Is Radiation Indicated And Are Fiducials Necessary? Nishita Kothary
16:50:00 END OF SESSION 13
16:50:00 Panel Discussion
16:55:00 SESSION 14 | MISCELLANEOUS TOPICS Riccardo Lencioni, Jafar Golzarian
17:00:00 Radiation Exposure Risk To Patients And Physicians
17:10:00 Ablation Therapy For Primary And Metastatic Lung Cancer Constantinos Sofocleous
17:20:00 Debate: Renal Cancer: There Is Little Or No Indication For Percutaneous Ablation Therapy Reza Ghavamian
17:30:00 Debate: Renal Cancer: There Are Many Situations Where Percutaneous Ablation Is Best Joshua L. Weintraub
17:40:00 New Advances In Pancreatic Therapy
17:50:00 The Filter Retrieval Clinic David W. Trost
18:00:00 Lymphatic Interventions: New Frontier Interventional Radiology Maxim Itkin
18:10:00 Panel Discussion
18:20:00 END OF SESSION 14
Friday, November 18, 2011
07:55:00 SESSION 16 | HANDS-ON WORKSHOPS/CASE PRESENTATIONS: ALL WORKSHOPS WILL COMBINE DIDACTIC LECTURES, CASE PRESENTATIONS AND HANDS-ON ACTIVITIES TO PROVIDE AN EDUCATIONAL EXPERIENCE FOR ALL LEVELS OF PARTICIPANTS.
07:55:00 SESSION 15 | HANDS-ON WORKSHOPS/CASE PRESENTATIONS: ALL WORKSHOPS WILL COMBINE DIDACTIC LECTURES, CASE PRESENTATIONS AND HANDS-ON ACTIVITIES TO PROVIDE AN EDUCATIONAL EXPERIENCE FOR ALL LEVELS OF PARTICIPANTS
08:00:00 SESSION 16 | PICC Lines, Advanced Training PICC placement using new technology allows for accurate placement without the need for x-ray documentation. Various devices will be described and available for hands-on evaluation. Also, new ultrasound technology will be demonstrated that assists in access of difficult veins. Yosef Golowa, Jacob Cynamon
08:00:00 SESSION 15 | PVD (Simulation Training Available) The evaluation and management of PVD remains an important aspect of IR practices. During this 1-hour workshop the latest techniques and devices will be discussed. New devices will be demonstrated. Current literature and randomized studies will be presented. Johannes Lammer
09:00:00 SESSION 15 | AAA: Endoleaks, Fenestrated Grafts, Percutaneous (Simulation Training Available) IR involvement in the management of patients with AAA range from the initial imaging workup to the actual performance of the endograft procedure. This workshop will highlight the areas that IR can be most helpful in an endograft program. Robert Lookstein, Ripal T. Gandhi, Michael D. Dake
09:00:00 SESSION 16 | Venous Disease Deep venous thrombosis, thrombolytic techniques and devices, and venous stents will be discussed in didactic, case presentation and hands-on approach. Yosef Golowa
10:00:00 SESSION 16 | Fibroids Indications, contraindications, complications, tools and embolic agents will be discussed in scientific and case based presentations. Yosef Golowa, Jafar Golzarian
10:00:00 SESSION 15 | Renal Artery PTA/Stent, Denervation (Simulation Training Available) Advances in renal intervention including recently published and ongoing studies will be presented. Indications for and description of a new technique, renal denervation, will be discussed. John Rundback, Marc Sapoval, Thomas A. Sos
11:00:00 SESSION 16 | Pulmonary AVMs, Peripheral AVMs, Varicoceles Some of the most difficult lesions we treat are in this category of disease. The experts discuss their approach to these lesions, how treatment can be simplified and how complications can be avoided. Robert J. Rosen, Jeffrey Pollak, Robert I. White, Lindsay Machan
11:00:00 SESSION 15 | Cardiology Tools For IR Interventional cardiologists have developed techniques and devices that are applicable in many ways to our practices. We have assembled a group of experts to describe devices and techniques that have been adopted from cardiology that are being used in IR. Eli Atar
12:00:00 SESSION 15 | CCSVI Patients with Multiple Sclerosis are asking for treatment. What have we learned over the past year? Are we helping? Are there studies to demonstrate the value of intervention? Should all patients be treated as part of a study? These questions and more will be discussed during this session. Lindsay Machan, Michael D. Dake, David Sperling, Salvatore J.A. Sclafani
12:00:00 SESSION 16 | TIPS/BRTO When does one perform a BRTO procedure as opposed to a TIPS? What pre-procedure information is needed to assure a successful procedure? Is early TIPS justified in patients with ascites? Paul J. Gaglio
13:00:00 SESSION 16 | Hands-On: Ablation Devices, Image Guidance Several ablation technologies are currently available including Radio Frequency, Micro Wave, Cryo and IRE. Many of the devices will be on hand so that the registrant will see the setup and the technique of performing ablations. Scientific data will be presented that will suggest why and when ablation treatment should be performed. Imaging guidance to perform complete and successful ablation will be discussed. Constantinos Sofocleous, Joshua L. Weintraub, Riccardo Lencioni
13:00:00 SESSION 15 | Closure And New Puncture Devices New closure devices have come to market over the past year. Techniques and complications related to these devices will be described. Closure devices and a new puncture device that eliminates the need for a closure device will be available for tableside deployment. Yosef Golowa, Jacob Cynamon, Joshua L. Weintraub
14:00:00 SESSION 15 | Vascular Imaging And CO2 Pre-procedure Vascular Imaging with CTA and MRA using post processing software has become routine in most labs. Advances in intra-procedural imaging using CO2 and Flouro-CT are becoming routine. These techniques, and how they help IR procedures will be discussed. Yosef Golowa, James Caridi, Robert Lookstein, Barry Eisenstein
14:00:00 SESSION 16 | Liver Cancer: Case Based Tumor Board Cases will be presented and discussed. TACE using conventional techniques or DEBs, ablation, Y 90 embolization, resection, and portal vein embolization will be discussed on a case by case basis. Riccardo Lencioni, Matthew S. Johnson, Riad Salem
14:55:00 SESSION 15 | END OF SESSION 15
15:00:00 SESSION 16 | Lung And Renal Cancer: Case Based Tumor Board Surgical vs. Percutaneous intervention. Selecting patients for percutaneous intervention, avoiding complications, managing complications, etc. Constantinos Sofocleous, Joshua L. Weintraub
16:00:00 SESSION 16 | Adjourn
16:05:00 SESSION 16 | END OF SESSION 16
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.